https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Biol Trace Elem Res 2000 Feb;73(2):97-111
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Biol Trace Elem Res 2000 Feb;73(2):97-1112000-02-01 00:00:002000-02-01 00:00:00Selenium and immunocompetence in patients with head and neck cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-152000-02-01 00:00:002019-02-15 08:51:15Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / J. Clin. Virol. 2000 Feb;16(1):1-152000-02-01 00:00:002019-02-15 09:22:30Newcastle disease virus (NDV): brief history of its oncolytic strains
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-82000-02-01 00:00:002019-02-15 08:45:17Clinical applications of dendritic cell vaccines
